ECOMB (ECOMB) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
31 Aug, 2026Executive summary
Completed a successful rights issue, raising 8 MSEK before costs, securing working capital for continued operations.
Achieved breakthroughs with new technologies (Ecotube DOS, Impulse Cleaning) and expanded partnerships, notably with RJM in the UK.
Continued focus on PFAS purification through subsidiary Ocean Recycle, targeting significant market opportunities.
Financial highlights
Net sales for H1 2026 reached 1,265 TSEK, up from 662 TSEK year-over-year.
Result after financial items improved to -2,199 TSEK (from -2,646 TSEK) for the group; parent company result -2,025 TSEK (-2,429 TSEK).
Cash and cash equivalents at period end: 447 TSEK (group), 281 TSEK (parent), both up from prior year.
Order backlog increased from 430 TSEK in Q1 2026 to 1,330 TSEK in Q2 2026.
Outlook and guidance
Positive outlook driven by stricter NOx regulations, demand for PFAS purification, and cost-effective carbon capture solutions.
Ongoing demo projects and new orders expected to support future growth.
Latest events from ECOMB
- Sales up, losses down, new projects and patents, but order backlog and warrant uptake declined.ECOMB
Q1 2026 - Financial turnaround driven by new capital, project wins, and strategic focus on CCS and PFAS.ECOMB
Q4 2025 - Sales fell, losses narrowed, and a major rights issue will fund new emission and water projects.ECOMB
Q3 2025 - Severe cash strain and losses persist, but future prospects hinge on new contracts and PFAS focus.ECOMB
Q2 2025 - Revenue surged on project delivery, but losses widened and liquidity remains tight.ECOMB
Q3 2024 - Sales up, losses incurred, capital raised, and new PFAS tech validated for future growth.ECOMB
Q2 2024 - Q1 2025 saw steep losses and cash strain, but key projects in NOx and PFAS advanced.ECOMB
Q1 2025 - Record revenue offset by project losses; PFAS focus and new patents drive future optimism.ECOMB
Q4 2024